CARDIOPROGRESS
Foundation for the advancement of cardiology

Cardioprogress Newsletter Dear Colleagues!
The Cardioprogress Foundation resumes publishing a quarterly newsletter dedicated to scientific news in cardiology. If you are interested in specific topics and details of scientific discoveries in the field of cardiology, please write to us. (The e-mail address is indicated on the last page of the newsletter).

Baxdrostat: A “Game Changer” for Hypertension? A new class of antihypertensive agent that blocks the production of aldosterone — a key hormone believed to drive increased blood pressure — has shown impressive results in one of the first pivotal phase 3 trials in patients with resistant or uncontrolled hypertension.

Al Stethoscope rolled out to 100 GP clinics to help diagnose heart failure GP clinics in London and Wales will receive an AI-powered tool as part of a trial to help improve the diagnosis of a deadly heart condition.

Classification Identifies Four Stages of Heart Attack The Canadian Cardiovascular Society (CCS) has developed a four-stage classification of acute atherothrombotic myocardial infarction (MI) based on the severity of the injury to the myocardium.

AHA Joins New Cardiovascular Certification Group ABCVM The American Heart Association (AHA) has now formally voted to join several other cardiovascular societies to form a new professional certification board for cardiovascular medicine, to be known as the American Board of Cardiovascular Medicine (ABCVM).

Coronary artery calcium: from risk prediction to treatment allocation and clinical trials Coronary artery calcium (CAC) is a direct measure of an individual’s coronary atherosclerotic burden.

FDA Okays First Extravascular ICD System The US Food and Drug Administration has approved Medtronic's novel "extravascular" implantable cardioverter-defibrillator (Aurora EV-ICD) system, which uses a single lead implanted substernally to allow anti-tachycardia pacing and low-energy defibrillation while avoiding the vascular space for lead placement.

New Tool to Guide Transcatheter Aortic Valve Replacement Researchers developed TJ-ICE–guided TAVR to facilitate implanting a heart valve at an optimal depth, guided by direct visualization of the membranous septum (MS) during the procedure.

Redefining CVD Risk: Cardiovascular-Kidney-Metabolic (CKM) Syndrome Citing the strong overlap between heart disease, kidney disease, type 2 diabetes, and obesity, the American Heart Association (AHA) has for the first time formally defined what they are calling cardiovascular-kidney-metabolic (CKM) syndrome.

ACP Revises Standard on Cardiorespiratory Death Determination The American College of Physicians (ACP) has issued a new position paper on determination of death that includes a clarification to the 1981 Uniform Determination of Death Act (UDDA), but otherwise reaffirms the current standards.